Nitrase Therapeutics

Jackson, United States

Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).

Nov 2021

Series A

Biotechnology Health Care Therapeutics

Top Investors

Sofinnova PartnersMichael J. Fox FoundationAbbVieDementia Discovery FundBristol-Myers Squibb

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nitrase Therapeutics

Who are Nitrase Therapeutics's investors?

Nitrase Therapeutics's investors include Sofinnova Partners, Michael J. Fox Foundation, AbbVie, Dementia Discovery Fund, Bristol-Myers Squibb.

Where is Nitrase Therapeutics headquartered?

Nitrase Therapeutics is headquartered in Jackson, United States.

What does Nitrase Therapeutics do?

Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).

What stage is Nitrase Therapeutics at?

Nitrase Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 2, 2021.

MLA

"Nitrase Therapeutics — Funding & Investors." VCBacked, November 2, 2021, https://www.vcbacked.co/company/nitrase-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). Nitrase Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/nitrase-therapeutics

Wikipedia (cite web)

{{cite web |title=Nitrase Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nitrase-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 2, 2021.